Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NYSE - Delayed Quote USD

Emergent BioSolutions Inc. (EBS)

Compare
7.71
-0.13
(-1.66%)
At close: February 21 at 4:00:01 PM EST
7.83
+0.12
+(1.56%)
After hours: 7:54:03 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
170,700
-206,300
-34,100
320,200
536,900
Investing Cash Flow
85,200
212,300
-381,300
-224,100
-151,900
Financing Cash Flow
-185,800
-535,700
481,200
-141,000
69,500
End Cash Position
157,900
111,700
642,600
576,300
621,500
Income Tax Paid Supplemental Data
50,000
52,800
6,200
71,600
109,300
Interest Paid Supplemental Data
67,600
68,300
33,000
30,400
21,000
Capital Expenditure
-32,600
-51,600
-115,800
-224,100
-141,900
Issuance of Capital Stock
9,500
8,400
--
--
--
Issuance of Debt
304,000
20,000
598,000
--
450,000
Repayment of Debt
-498,300
-563,400
-33,800
-35,900
-387,100
Repurchase of Capital Stock
--
--
-82,100
-106,000
--
Free Cash Flow
138,100
-257,900
-149,900
96,100
395,000
12/31/2020 - 11/15/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers